[Haemodynamic effect of triglycyl-lysine vasopressin (glypressin) on intravascular oesophageal variceal pressure in patients with cirrhosis. A randomized placebo controlled trial].
Fort
E
E
Service d'Hépato-Gástroentérologie et d'Assistance Nutritive, Hôpital Jean-Bernard, Poitiers.
D004341:Drug Evaluation; D004932:Esophageal and Gastric Varices / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010919:Placebos; D000077585:Terlipressin
D010919:Placebos; D008236:Lypressin; D000077585:Terlipressin
La glypressine réduit la pression intra-variqueuse oesophagienne.